{"@context":"https://schema.org","@type":"DietarySupplement","id":"https://nutripedia.co.uk/items/coq10","url":"https://nutripedia.co.uk/items/coq10","name":"Coenzyme Q10","category":"Wellness","tagline":"Mitochondrial cofactor — best evidence is for statin-associated muscle symptoms and heart failure.","verdict":"mixed","evidenceRating":3,"verdictSummary":"Cochrane review of CoQ10 for statin-induced myalgia (Banach et al., 2015 meta-analysis of 6 RCTs, n=302) found a small reduction in subjective muscle pain symptoms but inconsistent effects on objective markers like creatine kinase. The Q-SYMBIO RCT (n=420, 100 mg three times daily, 2 years) reported reduced major adverse cardiac events in heart failure patients on top of standard care. Evidence for benefit in healthy adults, fatigue, or cognition is weak. Not effective for primary prevention in the general population.","dosage":{"recommended":"100–200","unit":"mg/day","timing":"With a fat-containing meal — fat-soluble, absorption is poor on empty stomach","notes":"Heart failure trials (Q-SYMBIO) used 100 mg three times daily. Statin-associated muscle symptom trials typically used 100–200 mg/day for 8–12 weeks. Ubiquinol may be better absorbed in older adults and those with reduced reductase capacity, though head-to-head RCTs are limited. Effects build slowly — a 2–3 month trial is reasonable before judging response."},"keyBenefits":["May reduce subjective muscle pain in statin-treated patients (meta-analysis of 6 RCTs)","Q-SYMBIO RCT: reduced major adverse cardiac events in chronic heart failure as adjunct to standard care","Endogenous synthesis falls with age and is reduced by statins — supplementation has clear biological rationale","Useful adjunct in mitochondrial disorders under specialist supervision","Generally very well tolerated, even at high doses (>1,000 mg/day in trials)","Antioxidant in lipid membranes — regenerates vitamin E"],"warnings":["Not a substitute for prescribed statin therapy — discuss with GP before stopping any cardiac medication","Mild GI upset (nausea, diarrhoea) most commonly reported adverse effect","May reduce warfarin efficacy (structurally similar to vitamin K) — INR monitoring required","May modestly lower blood pressure and blood glucose — monitor if on antihypertensives or diabetes medication","No proven benefit for healthy adults seeking energy or anti-ageing effects","Quality varies — choose products with declared ubiquinone/ubiquinol form and reputable brands"],"evidenceSummary":null,"dosing":null,"safety":null,"whoMightBenefit":[],"whoShouldAvoid":[],"regulatoryNotes":null,"faqs":[{"question":"Does CoQ10 help with statin-induced muscle pain?","answer":"The Banach 2015 meta-analysis of 6 RCTs (n=302) reported a significant reduction in subjective muscle pain in statin-treated patients given CoQ10, but no consistent change in objective creatine kinase levels. The biological rationale is sound: statins inhibit HMG-CoA reductase, the same mevalonate pathway used to synthesise CoQ10, and statin therapy is documented to reduce circulating CoQ10 levels. However, larger high-quality RCTs (notably Taylor 2015) have not consistently shown benefit. Position is therefore mixed: a 8–12 week trial of 100–200 mg/day is reasonable for patients with statin-associated muscle symptoms, alongside their statin and after discussion with their GP — but it should not replace clinically indicated statin therapy."},{"question":"What did the Q-SYMBIO trial show for heart failure?","answer":"Q-SYMBIO (Mortensen 2014) was a multi-centre double-blind RCT in 420 patients with moderate-to-severe chronic heart failure, randomised to CoQ10 (100 mg three times daily) or placebo on top of standard care for 2 years. The trial reported a 50% reduction in major adverse cardiovascular events, 43% reduction in cardiovascular mortality, and 42% reduction in all-cause mortality. This is the strongest single trial supporting CoQ10 in any indication. Subsequent guidelines (notably the European Society of Cardiology) acknowledge the trial but stop short of routine recommendation pending further large-scale replication."},{"question":"What's the difference between ubiquinone and ubiquinol?","answer":"Ubiquinone is the oxidised form, ubiquinol is the reduced form. The body interconverts them via NQO1 reductase. Ubiquinol manufacturers argue it is better absorbed, particularly in older adults whose reductase activity may be reduced. Pharmacokinetic studies show modestly higher plasma CoQ10 with ubiquinol than equivalent doses of ubiquinone, but head-to-head RCTs measuring clinical outcomes (rather than just plasma levels) are very limited. For most users, ubiquinone is well-absorbed with a fat-containing meal and is substantially cheaper. Ubiquinol may be a reasonable choice for older adults, those with documented absorption issues, or where the budget allows."},{"question":"Is CoQ10 worth taking for healthy adults?","answer":"Evidence for benefit in healthy adults is weak. Endogenous CoQ10 synthesis declines with age, but no large RCT in healthy populations has demonstrated meaningful effect on energy levels, exercise performance, or longevity. The strongest indications remain heart failure (Q-SYMBIO), statin-associated muscle symptoms, and rare mitochondrial disorders under specialist supervision. Healthy adults seeking 'energy' or 'anti-ageing' effects from CoQ10 are working with marketing claims rather than robust trial data."},{"question":"Are there any drug interactions with CoQ10?","answer":"Two interactions are clinically important. First, CoQ10 is structurally similar to vitamin K and may reduce warfarin efficacy — INR monitoring is required if warfarin patients start CoQ10. Direct oral anticoagulants are less affected. Second, CoQ10 may modestly lower blood pressure and blood glucose; patients on antihypertensives or diabetes medication should monitor and inform their prescriber. Mild GI upset (nausea, diarrhoea) is the most commonly reported adverse effect. CoQ10 is otherwise very well tolerated, even at high doses (>1,000 mg/day in trial settings)."},{"question":"What dose of CoQ10 should I take?","answer":"Heart failure trials (Q-SYMBIO) used 100 mg three times daily (300 mg/day total). Statin-associated muscle symptom trials typically used 100–200 mg/day for 8–12 weeks. Effects build slowly — a 2–3 month trial is reasonable before judging response. CoQ10 is fat-soluble; absorption is markedly improved when taken with a fat-containing meal. Splitting larger daily doses into 2–3 portions further improves absorption. There is no established UK RNI; EFSA has not authorised a specific health claim for CoQ10 supplementation."}],"research":{"totalCount":0,"papers":[]},"machineReadable":{"markdownUrl":"https://nutripedia.co.uk/items/coq10/markdown","jsonUrl":"https://nutripedia.co.uk/items/coq10/json","llmsTxt":"https://nutripedia.co.uk/llms.txt"},"disclaimer":"Informational supplement research only. Not medical advice. Consult a qualified healthcare professional before taking supplements.","lastReviewed":"2026-05-04T00:00:00.000Z","updatedAt":"2026-05-04T00:00:00.000Z"}